BioNTech and CEPI partnership to advance mRNA Mpox Vaccine development
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
The partnership acknowledges the increasing mental health challenges faced by students in today's society
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Subscribe To Our Newsletter & Stay Updated